Early Pars Plana Vitrectomy and Anti-vascular Endothelial Growth Factor (VEGF) in the Management of Terson Syndrome: A Case Linked to Methicillin-Resistant Staphylococcus aureus (MRSA) Meningitis

早期玻璃体切除术和抗血管内皮生长因子(VEGF)治疗特森综合征:一例与耐甲氧西林金黄色葡萄球菌(MRSA)脑膜炎相关的病例

阅读:1

Abstract

We present a case of Terson syndrome, characterized by intraocular hemorrhage following acute intracranial events, which poses significant diagnostic and management challenges. The patient was a 45-year-old female with Terson syndrome associated with methicillin-resistant Staphylococcus aureus (MRSA) meningitis and ventriculitis. She presented with vision loss and was found to have sub-internal limiting membrane (sub-ILM) hemorrhages and dense vitreous hemorrhages. Early pars plana vitrectomy (PPV) in the left eye yielded substantial visual improvement. In contrast, delayed intervention in the right eye following anti-vascular endothelial growth factor (VEGF) therapy showed limited recovery. Systemic stabilization was achieved through targeted intravenous antibiotics. This report underscores the critical role of early surgical intervention and multidisciplinary management in optimizing visual and systemic outcomes in complex cases of Terson syndrome. The diagnostic significance of sub-ILM hemorrhage emphasizes its role as a specific marker of severe ocular involvement, necessitating prompt recognition and treatment.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。